Artificial Pancreas Systems Market: Favourable Healthcare Insurance Policies in North America to Boost Adoption of Advanced Diabetes Treatment Options: North America and Europe Industry Analysis and Opportunity Assessment, 2016-2026
- Healthcare, Pharmaceuticals and Medical devices
- No. of Pages: 121
- Published: 2017-03-01
- Report Code: REP-NA-3058
-
Format:
An Incisive, In-depth Analysis on the North America And Europe Artificial Pancreas Systems Market
This study offers a comprehensive, 360 degree analysis on the North America And Europe Artificial Pancreas Systems market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global North America And Europe Artificial Pancreas Systems market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
Diabetes Type 1 segment is likely to prevail over Diabetes Type 2 segment in the North America and Europe artificial pancreas systems market
The Diabetes Type 1 segment was estimated to account for a little more than 95% market share in terms of value in the North America and Europe artificial pancreas systems market by 2016 end and is expected to experience an increase of more than 200 BPS in its market share by 2026 over 2016. The Diabetes Type 1 segment is expected to register high Y-o-Y growth rates throughout the forecast period. Revenue contribution of this segment is projected to increase at a CAGR of 12.9% over the forecast period to reach more than US$ 250 Mn by 2026. On the other hand the Diabetes Type 2 segment is expected to register low Y-o-Y growth rates throughout the forecast period. Revenue contribution of this segment to the North America and Europe artificial pancreas systems market is expected to increase at a CAGR of 4.1% over the forecast period. The Diabetes Type 1 segment dominated the North America and Europe artificial pancreas systems market in revenue terms in 2015, and the trend is projected to continue throughout the forecast period. The Diabetes Type 2 segment is expected to remain the least attractive segment in the North America and Europe artificial pancreas systems market in revenue terms with a low market attractiveness index of 0.02 over the forecast period.
Alarming rise in population and economic burden of diabetes worldwide is anticipated to impact the artificial pancreas systems market in North America and Europe
Diabetes is one of the chronic and life-threatening diseases that affects a large part of the global population. Diabetes, also known as diabetes mellitus, is a metabolic disorder wherein the pancreas are either not able to produce insulin or the body is not able to utilise the existing insulin to metabolise glucose. Insulin is an essential secretion (hormone) of the body that metabolises glucose received by the body during and after a meal. An increasing burden of managing and controlling diabetes is the most important factor prompting demand for artificial pancreas systems among the global diabetic population.
Conventional systems used for diabetes management have many drawbacks including the need to take insulin injections at multiple times and recalibrating the CGM devices, thereby making management of diabetes quite tedious. However, artificial pancreas systems are designed to be more portable and user friendly. Artificial pancreas systems are technologically advanced. On the other hand, the conventional insulin pumps or CGM devices are large in size and thus, people have social and psychological stigma regarding conventional insulin devices, which motivates them to opt for artificial pancreas systems. This particular factor is creating a robust development in the North America and Europe artificial pancreas systems market.
Artificial pancreas systems are envisioned to deliver a complete system known as a closed loop system that mimics a pancreatic activity of maintaining blood glucose levels by coalescing several technologies including a glucose monitoring device, a glucose sensor with cutting-edge algorithm software and an insulin pump. Manufacturers are competing to provide such high-end artificial pancreas systems to attract diabetic patients who intend to improve diabetes management.
Diabetes Type 1 segment is projected to dominate the North America and Europe artificial pancreas systems market throughout the period of assessment
Diabetes Type 1 disease indication segment dominated the North America artificial pancreas systems market in revenue terms in 2015 and is projected to continue to do so throughout the forecast period, recording a market attractiveness index of 2.0. In Western and Eastern Europe this segment is expected to remain the dominant disease indication segment throughout the projected period.
Future Market Insights in its new publication titled “Artificial Pancreas Systems Market: North America and Europe Industry Analysis and Opportunity Assessment, 2016–2026,” explains that these products hold immense potential to significantly improve healthcare by enabling better diabetes management and thereby reduce doctor visits. Extensive research and development efforts by leading manufacturers in the market has led to identification and discovery of novel artificial pancreas systems, in turn delivering better insulin management. This 10-year comprehensive forecast of the North America and Europe artificial pancreas systems market further highlights the fact that an active engagement of clinical professional societies as well as several patient centralised organisations namely FDA, JDRF, HCT and NIH have contributed towards the implementation of effective strategies such as discovery and validation of products to advance in the field of diabetic research in order to improve patient health. Our analysts, after having extensively studied this market, have come to a conclusion that post insulin delivery, development of artificial pancreas systems is the most revolutionary advancement in diabetes care management.
While researching the North America and Europe artificial pancreas systems market, our analysts have found that the U.S. is the most lucrative market in the North American region, followed by Western Europe and Eastern Europe respectively over the forecast period. The artificial pancreas systems market in Eastern Europe is expected to witness comparatively less growth due to low awareness about diabetes in the region. However, countries such as Russia are experiencing noticeable advancements in delivering healthcare considering adoption of these systems by physicians for diabetes Type 1. We have also analysed the differentiating strategies where manufacturers are mainly focussed on developing low-cost artificial pancreas systems that are more user friendly and are integrated with glucose sensors to provide advanced diabetic control. Moreover, the analysts have observed that companies are focussing on integrating new technologies into their existing products. For instance, companies and manufacturers are focussing on developing a closed loop system to enable continuous insulin monitoring and management without any user input. Due to high prices and short life of sensors efforts are being taken to develop reliable and long durability sensors at low price points.
Our report provides key strategic recommendations for existing and new players in the North America and Europe artificial pancreas systems market
Primarily, the report takes an overview of the artificial pancreas systems market in North America and Europe. The overview mainly consists of market taxonomy and market dynamics, which underlines factors influencing the growth of the North America and Europe artificial pancreas systems market. It is followed by the list of artificial pancreas systems in the pipeline. This report covers the North America and Europe artificial pancreas systems market performance in terms of revenue contribution from various segments. The report also includes Future Market Insights’ analysis of key trends, drivers, restraints and opportunities, which are influencing the growth of the North America and Europe artificial pancreas systems market. Impact analysis of key regional growth drivers and restraints based on the weighted average model along with key region-specific trends is included in the report to better equip clients with information and hidden insights. We have also provided key strategic recommendations for both existing and new players in the North America and Europe artificial pancreas systems market to emerge sustainably profitable.
In the final section of the report, the North America and Europe artificial pancreas systems market landscape is included to provide report audiences with a dashboard view on the basis of categories of providers across the market, their presence in the North America and Europe artificial pancreas systems market and key differentiators.
North America and Europe artificial pancreas systems market: segmentation
|
By Region |
By Distribution Channel |
By Disease Indication |
|---|---|---|
|
|
|
In-depth secondary research is the key to ascertain overall market size and top products
The forecast presented in this report assesses the total revenue of the North America and Europe artificial pancreas systems market. When developing the market forecast, the starting point involves sizing up the current market, which forms the basis for forecasting how the market is anticipated to take shape in the near future. Given the volatile market characteristics, we have triangulated the outcome on the basis of analysis based on supply and demand sides. Yearly change in inflation rate has not been considered while forecasting market numbers. Bottom-up approach has been used to assess market numbers for the artificial pancreas systems market, while top-down approach has been used to counter-validate the reached market numbers. Macroeconomic indicators such as healthcare industry outlook, healthcare spending, FDA’s and JDRF’s contribution coupled with disease epidemiology have been considered to arrive at the indicated market numbers.
The report also takes into consideration year-on-year growth to understand the predictability of the market and to identify the right opportunities across the North America and Europe artificial pancreas systems market. As previously highlighted, the market for artificial pancreas systems is split into various categories. All these segments have been analysed in terms of Basis Point Share (BPS) to understand individual segments’ relative contribution to market growth. This detailed level of information is important for the identification of various key trends in the North America and Europe artificial pancreas systems market.
North America And Europe Artificial Pancreas Systems Market Reports - Table of Contents
1. Executive Summary
12. Assumptions and Acronyms Used
13. Research Methodology
North America And Europe Artificial Pancreas Systems Market Reports - List of Tables
Table 1: List of artificial pancreas device system (APDS) in pipeline
Table 2: North America and Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015–2026
Table 3: North America and Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015–2026
Table 4: North America and Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Region, 2015–2026
Table 5: North America Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2026
Table 6: North America Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015–2026
Table 7: North America Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015 – 2026
Table 8: Western Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2026
Table 9: Western Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015–2026
Table 10: Western Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015 – 2026
Table 11: Eastern Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2026
Table 12: Eastern Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015–2026
Table 13: Eastern Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015 – 2026
North America And Europe Artificial Pancreas Systems Market Reports - List of Figures
Figure 1: North America and Europe Artificial Pancreas Device System Market Value (US$ Mn) Forecast 2016 and 2026
Figure 2 : North America and Europe Artificial Pancreas Device System Market Split By Disease Indication (2015)
Figure 3 : North America and Europe Artificial Pancreas Device System Market Split By Distribution Channel (2015)
Figure 4: North America and Europe Artificial Pancreas Device System Market Split By Region (2015)
Figure 5: North America and Europe Artificial Pancreas Device System Market Value Analysis and Forecast, 2015–2026 (US$ Mn)
Figure 6: North America and Europe Artificial Pancreas Device System Market Size (US$ Mn) By Disease Indication, 2016 & 2026
Figure 7: North America and Europe Artificial Pancreas Device System Market Share Analysis (%) Disease Indication, 2016 & 2026
Figure 8: North America and Europe Artificial Pancreas Device System Market Y-o-Y Growth (%) By Disease Indication, 2015–2026
Figure 9: North America and Europe Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn) By Diabetes Type 1, 2015 – 2026
Figure 10: North America and Europe Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn) Segment, By Diabetes Type 2 2015 –2026
Figure 11: North America and Europe Artificial Pancreas Device System Market Attractiveness Analysis By Disease Indication, 2016–2026
Figure 12: North America and Europe Artificial Pancreas Device System Market Size (US$ Mn) By Distribution Channel, 2016 & 2026
Figure 13: North America and Europe Artificial Pancreas Device System Market Share Analysis (%) By Distribution Channel, 2016 & 2026
Figure 14: North America and Europe Artificial Pancreas Device System Market Y-o-Y Growth (%) By Distribution Channel, 2015–2026
Figure 15: North America and Europe Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn) By Hospitals Segment, 2015 – 2026
Figure 16: North America and Europe Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn) By E-Commerce Segment, 2015 – 2026
Figure 17: North America and Europe Artificial Pancreas Device System Market Attractiveness Analysis By Distribution Channel, 2016–2026
Figure 18: North America and Europe Artificial Pancreas Device System Market Size (US$ Mn) By Region, 2016 & 2026
Figure 19: North America and Europe Artificial Pancreas Device System Market Share Analysis (%) By Region, 2016 & 2026
Figure 20: North America and Europe Artificial Pancreas Device System Market Y-o-Y Growth (%) By Region, 2015–2026
Figure 21: North America Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 22: North America Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 23: Eastern Europe Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 24: North America and Europe Artificial Pancreas Device System Market Attractiveness Analysis By Region, 2016–2026
Figure 25: North America Artificial Pancreas Device System Market Share Analysis (%) By Country, 2016 & 2026
Figure 26: North America Artificial Pancreas Device System Market Y-o-Y Growth (%) By Country, 2015–2026
Figure 27: U.S. Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 28: Canada Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 29: North America Artificial Pancreas Device System Market Attractiveness Analysis By Country, 2016 – 2026
Figure 30: North America Artificial Pancreas Device System Market Attractiveness Analysis By Disease Indication 2016 – 2026
Figure 31: North America Artificial Pancreas Device System Market Attractiveness Analysis By Distribution Channel 2016 – 2026
Figure 32: Western Europe Artificial Pancreas Device System Market Share Analysis (%) By Country, 2016 & 2026
Figure 33: Western Europe Artificial Pancreas Device System Market Y-o-Y Growth (%) By Country, 2015–2026
Figure 34: Germany Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 35: France Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 36: Italy Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 37: Spain Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 38: The U.K. Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Get in touch
Harish Tiwari
Global Head - Business Development
Our Clients
CASE STUDIES
See how our work makes an impact.
At FMI, we design strategies that are adaptive, impactful, and implementable.